Passer au contenu principal

Subventions financées

Filtrer par:
Effacer les filtres
Filtrer par:

815 résultats trouvés

Investigation of microbiota mediated suppression of motor neuron degeneration in genetic models of ALS

Scientists have long wondered what the contribution of environment is to ALS and in recent years the idea that a combination of genetic susceptibility and environmental triggers has taken shape.


TYPE DE SUBVENTION
Subventions d'équipe
Domaine de recherche
Neurodégénérescence
Province
Québec
DATE DE DÉBUT
2017

Defining conserved functions of RNA binding proteins in stress-granule biogenesis

RNA is a mobile form of genetic information that is made from our DNA and its complex regulation is extremely important to the proper functioning of our cells.


TYPE DE SUBVENTION
Subventions d'équipe
Domaine de recherche
Neurodégénérescence
Province
Québec
DATE DE DÉBUT
2017

Impaired Neuromuscular Junction Connectivity in Amyotrophic Lateral Sclerosis

Many scientists believe that one of the earliest abnormalities in ALS is dysfunction at the place where motor neurons connect to muscle, known as the neuromuscular junction (NMJ).


TYPE DE SUBVENTION
Subventions d'équipe
Domaine de recherche
Neurodégénérescence
Province
Colombie-Britannique
DATE DE DÉBUT
2017

Mechanisms of in vitro synaptic transmission of mis-folded human SOD1

The process by which ALS spreads throughout the body remains a mystery, but Dr. Neil Cashman has spent decades looking at how abnormal changes in shape (scientifically called misfolding) of crucial proteins (the substances that do life processes) in our cells might propagate disease from one cell to another.


TYPE DE SUBVENTION
Subventions d'équipe
Domaine de recherche
Neurodégénérescence
Province
Colombie-Britannique
DATE DE DÉBUT
2017

Pathogenic mechanisms of C9ORF72 repeat expansion in ALS and development of therapeutics

Dr. Patten started his research career as a PhD student at the University of Alberta under the supervision of Dr. Declan Ali in 2004.


TYPE DE SUBVENTION
Subventions pour le renforcement des capacités
Domaine de recherche
Neurodégénérescence
Province
Québec
DATE DE DÉBUT
2017

Mechanisms of glutamatergic neuronal dysfunction in genetic models of ALS

This project will focus on comprehensively studying impaired transmission of signals (from the brain) at the location where neurons and muscles meet, called the neuromuscular junction.


TYPE DE SUBVENTION
Subventions pour le renforcement des capacités
Domaine de recherche
Neurodégénérescence
Province
Québec
DATE DE DÉBUT
2017

Development and validation of reagent kits for commercial high-throughput screening of PPI s and PPI inhibitors

Membrane proteins are biological molecules of incredible importance, playing diverse roles in many processes critical to life.


TYPE DE SUBVENTION
Subventions de la plate-forme
Domaine de recherche
Neurotechnologie
Concours
CQDM - Brain Canada - Quantum Leap
Province
Ontario
DATE DE DÉBUT
2017

The Aging Brain: Circadian, Transcriptomic, and Epigenomic Dimensions

One of the most important questions of biomedical research is “why do we ail as we age?”.


TYPE DE SUBVENTION
Subventions d'équipe
Domaine de recherche
Neurodégénérescence
Province
Ontario
DATE DE DÉBUT
2017

Montreal integrated neuropsychiatric cohort: Identifying subtypes of Autism and Schizophrenia integrating genomics, endophenotypes, and cohorts of high-risk genetic variants

Autism spectrum disorders (ASD) and schizophrenia (SZ) are two psychiatric conditions that affect approximately 2% of the general population. Genetic studies have identified mutations in hundreds of genes associated with ASD and SZ.


TYPE DE SUBVENTION
Subventions d'équipe
Domaine de recherche
Multiple
Province
Québec
DATE DE DÉBUT
2017

Using synthetic antibody parts to construct antibody-based imaging devices – anti-EGFR molecular targeted imaging probes for diagnosing and monitoring glioblastoma

To improve outcomes in brain cancer, better tools are needed to diagnose brain cancer, surgically remove brain tumours and monitor how they respond to therapy.


TYPE DE SUBVENTION
Subventions d'équipe
Domaine de recherche
Le cancer
Province
Saskatchewan
DATE DE DÉBUT
2017